Experience Matters: Creative Solutions to Overcome Challenges in Antibody Drug Discovery

PEGS Boston Virtual 2021 Presentation

Generating molecularly-diverse drug-quality antibodies can be difficult when working with challenging targets. AlivaMab Discovery Services combines Ablexis’ AlivaMab® Mouse, the leading platform for successful human therapeutic antibody discovery, with innovative technologies and deep expertise to deliver superior antibody therapeutics in rapid timelines – even for challenging targets. Watch as we review our antibody discovery approaches for challenging targets which yielded diverse leads.

Presenters:
Larry Green, PhD, CEO, Ablexis
John “Lippy” Lippincott, PhD, VP of Research, AlivaMab Discovery Services